TipRanks
Go Ultimate55% OFF

Celsius Holdings (CELH) AI Stock Analysis

MX:CELH

Celsius Holdings

(BMV:CELH)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Portfolio Growth and Market PositionStrong consolidated growth and approximately one-fifth of U.S. energy drink dollar purchases indicate meaningful market presence. Broad portfolio scale can improve retailer relevance, distribution productivity, and marketing efficiency, supporting durable growth beyond any single CELSIUS product cycle.
Negative Factors
Higher Financial LeverageThe sharp increase in leverage reduces financial flexibility compared with Celsius’s prior balance-sheet profile. Although cash generation is strong, higher debt raises the importance of maintaining earnings and cash flow, limiting room to absorb prolonged margin pressure or fund expansion solely internally.

Celsius Holdings (CELH) vs. SPDR S&P 500 ETF (SPY)

-80%-60%-40%-20%0%20%MX:CELH-51.53%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
MXN 7.37B
Dividend Yield
―
Average Volume (3M)
1,631
Price to Earnings (P/E)
138.7
Beta (1Y)
0.37
Revenue Growth
66.42%
EPS Growth
-46.84%
Country
Mexico
Employees
1,497
Sector
Consumer Defensive
Sector Strength
62
Industry
Beverages - Non-Alcoholic

Celsius Holdings Business Overview & Revenue Model

Company Description

Celsius Holdings, Inc. is a global enterprise specializing in the development, production, promotion, and distribution of functional beverages and liquid nutritional supplements. Its extensive reach covers North America, Europe, Asia, and other inter...

Celsius Holdings Earnings Call Summary

Earnings Call Date:Aug 05, 2026(Q2-2026)|% Change Since:7.12%|Next Earnings Date:Nov 04, 2026
Earnings Call SentimentPositive

The call presented a mixture of strong strategic and operational positives — portfolio revenue growth (+11%), breakout performance from Alani Nu (tracked growth ~56% in Q2 and H1 tracked sales >$1B), completed Rockstar integration, resilient gross margins (~48%) and disciplined SG&A — alongside meaningful short‑term execution challenges tied to SKU rationalization, shipment timing/inventory rebalancing, DSD mix and commodity headwinds that pressured reported net sales for brand CELSIUS and reduced Q2 adjusted EBITDA versus prior year. Management framed most issues as transitional with targeted fixes (innovation cadence, moving volume closer to retailers, revenue growth management, manufacturing ramp) and expects recovery into late 2026/2027.

Positive Updates

Consolidated Revenue Growth
Second quarter revenue of $818 million, up approximately 11% year‑over‑year as a combined portfolio.

Negative Updates

CELSIUS Net Sales Decline and Short‑term Weakness
Brand CELSIUS net sales were down approximately 12% year‑over‑year in Q2; retail sales in tracked channels declined ~2% in the quarter. Management expects Q3 to look similar to Q2 for CELSIUS before returning to growth late in the year/into 2027. The 16‑ounce line remains a specific area of weakness with innovation planned in early 2027.

Company Guidance

Management guided that the third quarter should look largely like Q2 as the CELSIUS SKU rationalization and inventory rebalancing continue, with the company exiting 2026 back into growth; Q2 revenue was $818 million, CELSIUS net sales were down ~12% year‑over‑year (scanner dollars down ~2%), dollars per point of distribution rose ~16% from Q1 to Q2 on ~7% fewer points, and Fizz‑Free dollar sales in tracked channels grew >20% Q2 vs Q1. Brand-level results included Alani Nu net sales of ≈$364 million (≈+21% Y/Y; tracked channel dollar growth ≈56%; all‑in gross revenue ex‑Canada/non‑RTD ≈39% vs net ≈21%) and Rockstar net sales of ≈$66 million; depletions versus orders explained roughly half the gap between scanner and reported results. Profitability guidance: gross margin was ~48% in Q2 (also Q1) and management expects Q3 to remain in the high‑40s with upside if diesel or aluminum costs moderate; adjusted EBITDA was $184 million (~22.5% of revenue) in Q2 ($380M for H1, ≈23.7% of revenue) and adjusted SG&A was 28.6% of revenue (GAAP SG&A $238M, 29% of revenue). Capital allocation and ops metrics: the company repurchased ≈$100M in Q2 (≈$124M H1) against a $300M authorization, reduced its interest rate by 25 bps with potential for another 25 bps, expects its second North Carolina manufacturing line to begin producing in H2 with full benefit in 2027, and targets international markets to represent more than 15% of revenue over the next five years.

Celsius Holdings Risk Analysis

Celsius Holdings disclosed 1 risk factors in its most recent earnings report. Celsius Holdings reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

Celsius Holdings Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

MX:CELH against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
MNSTMNST79Outperform$92.74B43.4324.96%―20.37%34.79%
PEPPEP73Outperform$187.16B17.2350.62%4.23%6.36%51.39%
FIZZFIZZ66Neutral$3.30B18.9832.60%―-1.80%-5.87%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
ZVIAZVIA57Neutral$92.04M-8.93-19.05%―7.22%42.48%
KDPKDP56Neutral$48.77B36.055.64%2.57%27.48%-12.53%

* Consumer Defensive Sector Average

Performance Comparison

-50%-25%0%25%50%MX:CELHKDPMNSTFIZZPEPZVIADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
MX:CELH and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MX:CELHCelsius Holdings540.00-560.00-50.91%
KDPKeurig Dr Pepper35.8410.0238.82%
MNSTMonster Beverage47.3414.0942.35%
FIZZNational Beverage35.305.2217.35%
PEPPepsico137.34-0.67-0.48%
ZVIAZevia Pbc Class A1.19-1.19-50.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.